Proteomics

Dataset Information

0

Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment


ABSTRACT: HSP90 inhibitors can target many oncoproteins simultaneously, but none have made it through clinical trials due to dose-limiting toxicity and induction of heat shock response, leading to clinical resistance. We identified diptoindonesin G (dip G) as an HSP90 modulator that can promote degradation of HSP90 clients by binding to the middle domain of HSP90 without inducing heat shock response. Although dip G does not bind to the ligand binding domain (LBD) of estrogen receptor (ER), it promotes degradation of ER in breast cancer cells. We further showed that treatment of ER LBD mutantexpressing cells with dip G promoted degradation of wild type and mutant ER with similar efficacy, downregulated ER-regulated gene expression, and inhibited cell proliferation. Our data suggest that dip G circumvents some obstacles associated with HSP90 inhibition and may be developed as a new therapeutic avenue to various cancers, particularly endocrine resistant breast cancer harboring ESR1 mutations

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Min Ma  

LAB HEAD: Wei Xu

PROVIDER: PXD035398 | Pride | 2022-11-16

REPOSITORIES: Pride

Similar Datasets

2016-05-16 | E-MTAB-4075 | biostudies-arrayexpress
2012-05-14 | E-GEOD-35812 | biostudies-arrayexpress
2021-04-07 | GSE164717 | GEO
2007-06-01 | E-ATMX-12 | biostudies-arrayexpress
2021-07-02 | PXD016174 | Pride
2012-05-15 | GSE35812 | GEO
2019-11-08 | GSE126151 | GEO
2015-07-14 | E-GEOD-66369 | biostudies-arrayexpress
2009-11-15 | GSE13401 | GEO
2014-03-26 | GSE56186 | GEO